* Price Registration * Acquisition Of Medicines And/Or Health Products, Which Were Granted In The Presentations And Concentrations Registered With Anvisa Prescribed In The Medical Prescriptions Present In The Lawsuits. Agreement 87 Galantamine Hydrobromide, 8 Mg Hard Cap Lib Prol Quetiapine Hemifumarate, 200 Mg With Rev Lib Prol Insulin Aspart, 100 U/Ml Injectable X 3Ml Insulin Glargine, 300 U/Ml Sol Inj X 1.5 Ml Insulin Glulisine, 100 U/Ml Injectable X 3Ml Insulin Lispro, 100 Ui/Ml Sol Inj X 3 Ml Human Immunoglobulin, Subcutaneous Injectable 10%. Benserazide Hydrochloride + Levodopa, 100 Mg + 25 Mg With Miglustat, 100 Mg Cap Tafamidis Meglumine, 20 Mg Soft Cap Trastuzumab, 150 Mg Po Liof Sol Inj

Secretaria Estadual da Saude Brazil has Released a tender for * Price Registration * Acquisition Of Medicines And/Or Health Products, Which Were Granted In The Presentations And Concentrations Registered With Anvisa Prescribed In The Medical Prescriptions Present In The Lawsuits. Agreement 87 Galantamine Hydrobromide, 8 Mg Hard Cap Lib Prol Quetiapine Hemifumarate, 200 Mg With Rev Lib Prol Insulin Aspart, 100 U/Ml Injectable X 3Ml Insulin Glargine, 300 U/Ml Sol Inj X 1.5 Ml Insulin Glulisine, 100 U/Ml Injectable X 3Ml Insulin Lispro, 100 Ui/Ml Sol Inj X 3 Ml Human Immunoglobulin, Subcutaneous Injectable 10%. Benserazide Hydrochloride + Levodopa, 100 Mg + 25 Mg With Miglustat, 100 Mg Cap Tafamidis Meglumine, 20 Mg Soft Cap Trastuzumab, 150 Mg Po Liof Sol Inj in Healthcare and Medicine. The tender was released on Jan 14, 2025.

Country - Brazil

Summary - * Price Registration * Acquisition Of Medicines And/Or Health Products, Which Were Granted In The Presentations And Concentrations Registered With Anvisa Prescribed In The Medical Prescriptions Present In The Lawsuits. Agreement 87 Galantamine Hydrobromide, 8 Mg Hard Cap Lib Prol Quetiapine Hemifumarate, 200 Mg With Rev Lib Prol Insulin Aspart, 100 U/Ml Injectable X 3Ml Insulin Glargine, 300 U/Ml Sol Inj X 1.5 Ml Insulin Glulisine, 100 U/Ml Injectable X 3Ml Insulin Lispro, 100 Ui/Ml Sol Inj X 3 Ml Human Immunoglobulin, Subcutaneous Injectable 10%. Benserazide Hydrochloride + Levodopa, 100 Mg + 25 Mg With Miglustat, 100 Mg Cap Tafamidis Meglumine, 20 Mg Soft Cap Trastuzumab, 150 Mg Po Liof Sol Inj

Deadline - Jan 30, 2025

GT reference number - 101478018

Product classification - Medical equipments, pharmaceuticals and personal care products